Olivia Gordon

Olivia Gordon

Auto-generated profile, based on publicly available information

Olivia Gordon

Department of Urology, School of Medicine, George Washington University, Washington, DC 20052, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2024 in Current Oncology
Verified
Journal Article
Open access
PDF file
RARyan M. Antar
Ryan M. Antar
VXVincent Eric Xu
Vincent Eric Xu
OAOluwafolajimi Adesanya
Oluwafolajimi Adesanya
ADArthur Drouaud
Arthur Drouaud
NLNoah Longton
Noah Longton
MWMichael Whalen
Michael Whalen
Background: Muscle-invasive bladder cancer (MIBC) is a potentially fatal disease, especially in the setting of locally advanced or node-positive disease. Adverse outcomes have also primarily been associated with low-income status, as has been reported in other cancers. While the adoption of neoadjuvant cisplatin-based chemotherapy (NAC) followed by radical cystectomy (RC) and pelvic lymph node dissection (PLND) has improved outcomes, these standard-of-care treatments may be underutilized in lower-income patients. We sought to investigate the economic disparities in NAC and PLND receipt and survival outcomes in MIBC. Methods: Utilizing the National Cancer Database, a retrospective cohort analysis of cT2-4N0-3M0 BCa patients with urothelial histology who underwent RC was conducted. The impact of income level on overall survival (OS) and the likelihood of receiving NAC and PLND was evaluated. Results: A total of 25,823 patients were included. This study found that lower-income patients were less likely to receive NAC and adequate PLND (≥15 LNs). Moreover, lower-income patients exhibited worse OS (Median OS 55.9 months vs. 68.2 months, p < 0.001). Our findings also demonstrated that higher income, treatment at academic facilities, and recent years of diagnosis were associated with an increased likelihood of receiving standard-of-care modalities and improved survival. Conclusions: Even after controlling for clinicodemographic variables, income independently influenced the receipt of standard MIBC treatments and survival. Our findings identify an opportunity to improve the quality of care for lower-income MIBC patients through concerted efforts to regionalize multi-modal urologic oncology care.

7 June 2023 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
CKCharles Klose
Charles Klose
OGOlivia Gordon
Olivia Gordon
ASAndrew Sparks
Andrew Sparks
MWMichael Whalen
Michael Whalen